ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dextromethorphan Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-3X6204
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Dextromethorphan Market Insights and Forecast to 2028
BUY CHAPTERS

Global Dextromethorphan Market Research Report 2025

Code: QYRE-Auto-3X6204
Report
September 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
TEVA
Sanofi
Johnson & Johnson
Bayer
Bristol–Myers Squibb
GSK
IriSys R&D
TSH Biopharm
Endo International
Axsome Therapeutics
Strive Pharmaceuticals
Cellix Bio
Stada Arzneimittel
Yabo Pharmaceutical
Zhuhai Tianda Pharma
Sichuan Shenghe Pharmaceutical
Zhejiang Kangde Pharmaceutical Group
Zhejiang Anbao Pharmaceutical
Jiangsu Zhongtian Pharmaceutical
Johnson & Johnson
IriSys R&D

Dextromethorphan Market

The global market for Dextromethorphan was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The d-isomer of the codeine analog of levorphanol. Dextromethorphan shows high affinity binding to several regions of the brain, including the medullary cough center. This compound is an NMDA receptor antagonist (receptors, N-methyl-D-aspartate) and acts as a non-competitive channel blocker. It is one of the widely used antitussives, and is also used to study the involvement of glutamate receptors in neurotoxicity.
North American market for Dextromethorphan is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Dextromethorphan is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Dextromethorphan in Cold is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Dextromethorphan include Teva, Sanofi, Johnson & Johnson, Bayer, Bristol-Myers Squibb, GSK, IriSys R&D, TSH Biopharm, Endo International, Axsome Therapeutics, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dextromethorphan, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dextromethorphan.
The Dextromethorphan market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dextromethorphan market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dextromethorphan companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Dextromethorphan Market Report

Report Metric Details
Report Name Dextromethorphan Market
Segment by Type
  • Tablets
  • Syrups
Segment by Application
  • Cold
  • Acute Or Chronic Bronchitis
  • Bronchial Asthma
  • Sore Throat
  • Tuberculosis (TB)
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Teva, Sanofi, Johnson & Johnson, Bayer, Bristol-Myers Squibb, GSK, IriSys R&D, TSH Biopharm, Endo International, Axsome Therapeutics, Strive Pharmaceuticals, Cellix Bio, Stada Arzneimittel, Yabo Pharmaceutical, Zhuhai Tianda Pharma, Sichuan Shenghe Pharmaceutical, Zhejiang Kangde Pharmaceutical Group, Zhejiang Anbao Pharmaceutical, Jiangsu Zhongtian Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Dextromethorphan company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Dextromethorphan Market report?

Ans: The main players in the Dextromethorphan Market are Teva, Sanofi, Johnson & Johnson, Bayer, Bristol-Myers Squibb, GSK, IriSys R&D, TSH Biopharm, Endo International, Axsome Therapeutics, Strive Pharmaceuticals, Cellix Bio, Stada Arzneimittel, Yabo Pharmaceutical, Zhuhai Tianda Pharma, Sichuan Shenghe Pharmaceutical, Zhejiang Kangde Pharmaceutical Group, Zhejiang Anbao Pharmaceutical, Jiangsu Zhongtian Pharmaceutical

What are the Application segmentation covered in the Dextromethorphan Market report?

Ans: The Applications covered in the Dextromethorphan Market report are Cold, Acute Or Chronic Bronchitis, Bronchial Asthma, Sore Throat, Tuberculosis (TB)

What are the Type segmentation covered in the Dextromethorphan Market report?

Ans: The Types covered in the Dextromethorphan Market report are Tablets, Syrups

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dextromethorphan Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablets
1.2.3 Syrups
1.3 Market by Application
1.3.1 Global Dextromethorphan Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cold
1.3.3 Acute Or Chronic Bronchitis
1.3.4 Bronchial Asthma
1.3.5 Sore Throat
1.3.6 Tuberculosis (TB)
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dextromethorphan Market Perspective (2020-2031)
2.2 Global Dextromethorphan Growth Trends by Region
2.2.1 Global Dextromethorphan Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Dextromethorphan Historic Market Size by Region (2020-2025)
2.2.3 Dextromethorphan Forecasted Market Size by Region (2026-2031)
2.3 Dextromethorphan Market Dynamics
2.3.1 Dextromethorphan Industry Trends
2.3.2 Dextromethorphan Market Drivers
2.3.3 Dextromethorphan Market Challenges
2.3.4 Dextromethorphan Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Dextromethorphan Players by Revenue
3.1.1 Global Top Dextromethorphan Players by Revenue (2020-2025)
3.1.2 Global Dextromethorphan Revenue Market Share by Players (2020-2025)
3.2 Global Dextromethorphan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Dextromethorphan Revenue
3.4 Global Dextromethorphan Market Concentration Ratio
3.4.1 Global Dextromethorphan Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dextromethorphan Revenue in 2024
3.5 Global Key Players of Dextromethorphan Head office and Area Served
3.6 Global Key Players of Dextromethorphan, Product and Application
3.7 Global Key Players of Dextromethorphan, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Dextromethorphan Breakdown Data by Type
4.1 Global Dextromethorphan Historic Market Size by Type (2020-2025)
4.2 Global Dextromethorphan Forecasted Market Size by Type (2026-2031)
5 Dextromethorphan Breakdown Data by Application
5.1 Global Dextromethorphan Historic Market Size by Application (2020-2025)
5.2 Global Dextromethorphan Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Dextromethorphan Market Size (2020-2031)
6.2 North America Dextromethorphan Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Dextromethorphan Market Size by Country (2020-2025)
6.4 North America Dextromethorphan Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Dextromethorphan Market Size (2020-2031)
7.2 Europe Dextromethorphan Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Dextromethorphan Market Size by Country (2020-2025)
7.4 Europe Dextromethorphan Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Dextromethorphan Market Size (2020-2031)
8.2 Asia-Pacific Dextromethorphan Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Dextromethorphan Market Size by Region (2020-2025)
8.4 Asia-Pacific Dextromethorphan Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Dextromethorphan Market Size (2020-2031)
9.2 Latin America Dextromethorphan Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Dextromethorphan Market Size by Country (2020-2025)
9.4 Latin America Dextromethorphan Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Dextromethorphan Market Size (2020-2031)
10.2 Middle East & Africa Dextromethorphan Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Dextromethorphan Market Size by Country (2020-2025)
10.4 Middle East & Africa Dextromethorphan Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Dextromethorphan Introduction
11.1.4 Teva Revenue in Dextromethorphan Business (2020-2025)
11.1.5 Teva Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Dextromethorphan Introduction
11.2.4 Sanofi Revenue in Dextromethorphan Business (2020-2025)
11.2.5 Sanofi Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Dextromethorphan Introduction
11.3.4 Johnson & Johnson Revenue in Dextromethorphan Business (2020-2025)
11.3.5 Johnson & Johnson Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Dextromethorphan Introduction
11.4.4 Bayer Revenue in Dextromethorphan Business (2020-2025)
11.4.5 Bayer Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb Dextromethorphan Introduction
11.5.4 Bristol-Myers Squibb Revenue in Dextromethorphan Business (2020-2025)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 GSK
11.6.1 GSK Company Details
11.6.2 GSK Business Overview
11.6.3 GSK Dextromethorphan Introduction
11.6.4 GSK Revenue in Dextromethorphan Business (2020-2025)
11.6.5 GSK Recent Development
11.7 IriSys R&D
11.7.1 IriSys R&D Company Details
11.7.2 IriSys R&D Business Overview
11.7.3 IriSys R&D Dextromethorphan Introduction
11.7.4 IriSys R&D Revenue in Dextromethorphan Business (2020-2025)
11.7.5 IriSys R&D Recent Development
11.8 TSH Biopharm
11.8.1 TSH Biopharm Company Details
11.8.2 TSH Biopharm Business Overview
11.8.3 TSH Biopharm Dextromethorphan Introduction
11.8.4 TSH Biopharm Revenue in Dextromethorphan Business (2020-2025)
11.8.5 TSH Biopharm Recent Development
11.9 Endo International
11.9.1 Endo International Company Details
11.9.2 Endo International Business Overview
11.9.3 Endo International Dextromethorphan Introduction
11.9.4 Endo International Revenue in Dextromethorphan Business (2020-2025)
11.9.5 Endo International Recent Development
11.10 Axsome Therapeutics
11.10.1 Axsome Therapeutics Company Details
11.10.2 Axsome Therapeutics Business Overview
11.10.3 Axsome Therapeutics Dextromethorphan Introduction
11.10.4 Axsome Therapeutics Revenue in Dextromethorphan Business (2020-2025)
11.10.5 Axsome Therapeutics Recent Development
11.11 Strive Pharmaceuticals
11.11.1 Strive Pharmaceuticals Company Details
11.11.2 Strive Pharmaceuticals Business Overview
11.11.3 Strive Pharmaceuticals Dextromethorphan Introduction
11.11.4 Strive Pharmaceuticals Revenue in Dextromethorphan Business (2020-2025)
11.11.5 Strive Pharmaceuticals Recent Development
11.12 Cellix Bio
11.12.1 Cellix Bio Company Details
11.12.2 Cellix Bio Business Overview
11.12.3 Cellix Bio Dextromethorphan Introduction
11.12.4 Cellix Bio Revenue in Dextromethorphan Business (2020-2025)
11.12.5 Cellix Bio Recent Development
11.13 Stada Arzneimittel
11.13.1 Stada Arzneimittel Company Details
11.13.2 Stada Arzneimittel Business Overview
11.13.3 Stada Arzneimittel Dextromethorphan Introduction
11.13.4 Stada Arzneimittel Revenue in Dextromethorphan Business (2020-2025)
11.13.5 Stada Arzneimittel Recent Development
11.14 Yabo Pharmaceutical
11.14.1 Yabo Pharmaceutical Company Details
11.14.2 Yabo Pharmaceutical Business Overview
11.14.3 Yabo Pharmaceutical Dextromethorphan Introduction
11.14.4 Yabo Pharmaceutical Revenue in Dextromethorphan Business (2020-2025)
11.14.5 Yabo Pharmaceutical Recent Development
11.15 Zhuhai Tianda Pharma
11.15.1 Zhuhai Tianda Pharma Company Details
11.15.2 Zhuhai Tianda Pharma Business Overview
11.15.3 Zhuhai Tianda Pharma Dextromethorphan Introduction
11.15.4 Zhuhai Tianda Pharma Revenue in Dextromethorphan Business (2020-2025)
11.15.5 Zhuhai Tianda Pharma Recent Development
11.16 Sichuan Shenghe Pharmaceutical
11.16.1 Sichuan Shenghe Pharmaceutical Company Details
11.16.2 Sichuan Shenghe Pharmaceutical Business Overview
11.16.3 Sichuan Shenghe Pharmaceutical Dextromethorphan Introduction
11.16.4 Sichuan Shenghe Pharmaceutical Revenue in Dextromethorphan Business (2020-2025)
11.16.5 Sichuan Shenghe Pharmaceutical Recent Development
11.17 Zhejiang Kangde Pharmaceutical Group
11.17.1 Zhejiang Kangde Pharmaceutical Group Company Details
11.17.2 Zhejiang Kangde Pharmaceutical Group Business Overview
11.17.3 Zhejiang Kangde Pharmaceutical Group Dextromethorphan Introduction
11.17.4 Zhejiang Kangde Pharmaceutical Group Revenue in Dextromethorphan Business (2020-2025)
11.17.5 Zhejiang Kangde Pharmaceutical Group Recent Development
11.18 Zhejiang Anbao Pharmaceutical
11.18.1 Zhejiang Anbao Pharmaceutical Company Details
11.18.2 Zhejiang Anbao Pharmaceutical Business Overview
11.18.3 Zhejiang Anbao Pharmaceutical Dextromethorphan Introduction
11.18.4 Zhejiang Anbao Pharmaceutical Revenue in Dextromethorphan Business (2020-2025)
11.18.5 Zhejiang Anbao Pharmaceutical Recent Development
11.19 Jiangsu Zhongtian Pharmaceutical
11.19.1 Jiangsu Zhongtian Pharmaceutical Company Details
11.19.2 Jiangsu Zhongtian Pharmaceutical Business Overview
11.19.3 Jiangsu Zhongtian Pharmaceutical Dextromethorphan Introduction
11.19.4 Jiangsu Zhongtian Pharmaceutical Revenue in Dextromethorphan Business (2020-2025)
11.19.5 Jiangsu Zhongtian Pharmaceutical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
TEVA
Sanofi
Johnson & Johnson
Bayer
Bristol–Myers Squibb
GSK
IriSys R&D
TSH Biopharm
Endo International
Axsome Therapeutics
Strive Pharmaceuticals
Cellix Bio
Stada Arzneimittel
Yabo Pharmaceutical
Zhuhai Tianda Pharma
Sichuan Shenghe Pharmaceutical
Zhejiang Kangde Pharmaceutical Group
Zhejiang Anbao Pharmaceutical
Jiangsu Zhongtian Pharmaceutical
Johnson & Johnson
IriSys R&D
List of Tables
 Table 1. Global Dextromethorphan Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Tablets
 Table 3. Key Players of Syrups
 Table 4. Global Dextromethorphan Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Dextromethorphan Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Dextromethorphan Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Dextromethorphan Market Share by Region (2020-2025)
 Table 8. Global Dextromethorphan Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Dextromethorphan Market Share by Region (2026-2031)
 Table 10. Dextromethorphan Market Trends
 Table 11. Dextromethorphan Market Drivers
 Table 12. Dextromethorphan Market Challenges
 Table 13. Dextromethorphan Market Restraints
 Table 14. Global Dextromethorphan Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Dextromethorphan Market Share by Players (2020-2025)
 Table 16. Global Top Dextromethorphan Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dextromethorphan as of 2024)
 Table 17. Ranking of Global Top Dextromethorphan Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Dextromethorphan Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Dextromethorphan, Headquarters and Area Served
 Table 20. Global Key Players of Dextromethorphan, Product and Application
 Table 21. Global Key Players of Dextromethorphan, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Dextromethorphan Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Dextromethorphan Revenue Market Share by Type (2020-2025)
 Table 25. Global Dextromethorphan Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Dextromethorphan Revenue Market Share by Type (2026-2031)
 Table 27. Global Dextromethorphan Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Dextromethorphan Revenue Market Share by Application (2020-2025)
 Table 29. Global Dextromethorphan Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Dextromethorphan Revenue Market Share by Application (2026-2031)
 Table 31. North America Dextromethorphan Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Dextromethorphan Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Dextromethorphan Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Dextromethorphan Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Dextromethorphan Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Dextromethorphan Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Dextromethorphan Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Dextromethorphan Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Dextromethorphan Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Dextromethorphan Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Dextromethorphan Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Dextromethorphan Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Dextromethorphan Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Dextromethorphan Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Dextromethorphan Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Teva Company Details
 Table 47. Teva Business Overview
 Table 48. Teva Dextromethorphan Product
 Table 49. Teva Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 50. Teva Recent Development
 Table 51. Sanofi Company Details
 Table 52. Sanofi Business Overview
 Table 53. Sanofi Dextromethorphan Product
 Table 54. Sanofi Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 55. Sanofi Recent Development
 Table 56. Johnson & Johnson Company Details
 Table 57. Johnson & Johnson Business Overview
 Table 58. Johnson & Johnson Dextromethorphan Product
 Table 59. Johnson & Johnson Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 60. Johnson & Johnson Recent Development
 Table 61. Bayer Company Details
 Table 62. Bayer Business Overview
 Table 63. Bayer Dextromethorphan Product
 Table 64. Bayer Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 65. Bayer Recent Development
 Table 66. Bristol-Myers Squibb Company Details
 Table 67. Bristol-Myers Squibb Business Overview
 Table 68. Bristol-Myers Squibb Dextromethorphan Product
 Table 69. Bristol-Myers Squibb Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 70. Bristol-Myers Squibb Recent Development
 Table 71. GSK Company Details
 Table 72. GSK Business Overview
 Table 73. GSK Dextromethorphan Product
 Table 74. GSK Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 75. GSK Recent Development
 Table 76. IriSys R&D Company Details
 Table 77. IriSys R&D Business Overview
 Table 78. IriSys R&D Dextromethorphan Product
 Table 79. IriSys R&D Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 80. IriSys R&D Recent Development
 Table 81. TSH Biopharm Company Details
 Table 82. TSH Biopharm Business Overview
 Table 83. TSH Biopharm Dextromethorphan Product
 Table 84. TSH Biopharm Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 85. TSH Biopharm Recent Development
 Table 86. Endo International Company Details
 Table 87. Endo International Business Overview
 Table 88. Endo International Dextromethorphan Product
 Table 89. Endo International Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 90. Endo International Recent Development
 Table 91. Axsome Therapeutics Company Details
 Table 92. Axsome Therapeutics Business Overview
 Table 93. Axsome Therapeutics Dextromethorphan Product
 Table 94. Axsome Therapeutics Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 95. Axsome Therapeutics Recent Development
 Table 96. Strive Pharmaceuticals Company Details
 Table 97. Strive Pharmaceuticals Business Overview
 Table 98. Strive Pharmaceuticals Dextromethorphan Product
 Table 99. Strive Pharmaceuticals Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 100. Strive Pharmaceuticals Recent Development
 Table 101. Cellix Bio Company Details
 Table 102. Cellix Bio Business Overview
 Table 103. Cellix Bio Dextromethorphan Product
 Table 104. Cellix Bio Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 105. Cellix Bio Recent Development
 Table 106. Stada Arzneimittel Company Details
 Table 107. Stada Arzneimittel Business Overview
 Table 108. Stada Arzneimittel Dextromethorphan Product
 Table 109. Stada Arzneimittel Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 110. Stada Arzneimittel Recent Development
 Table 111. Yabo Pharmaceutical Company Details
 Table 112. Yabo Pharmaceutical Business Overview
 Table 113. Yabo Pharmaceutical Dextromethorphan Product
 Table 114. Yabo Pharmaceutical Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 115. Yabo Pharmaceutical Recent Development
 Table 116. Zhuhai Tianda Pharma Company Details
 Table 117. Zhuhai Tianda Pharma Business Overview
 Table 118. Zhuhai Tianda Pharma Dextromethorphan Product
 Table 119. Zhuhai Tianda Pharma Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 120. Zhuhai Tianda Pharma Recent Development
 Table 121. Sichuan Shenghe Pharmaceutical Company Details
 Table 122. Sichuan Shenghe Pharmaceutical Business Overview
 Table 123. Sichuan Shenghe Pharmaceutical Dextromethorphan Product
 Table 124. Sichuan Shenghe Pharmaceutical Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 125. Sichuan Shenghe Pharmaceutical Recent Development
 Table 126. Zhejiang Kangde Pharmaceutical Group Company Details
 Table 127. Zhejiang Kangde Pharmaceutical Group Business Overview
 Table 128. Zhejiang Kangde Pharmaceutical Group Dextromethorphan Product
 Table 129. Zhejiang Kangde Pharmaceutical Group Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 130. Zhejiang Kangde Pharmaceutical Group Recent Development
 Table 131. Zhejiang Anbao Pharmaceutical Company Details
 Table 132. Zhejiang Anbao Pharmaceutical Business Overview
 Table 133. Zhejiang Anbao Pharmaceutical Dextromethorphan Product
 Table 134. Zhejiang Anbao Pharmaceutical Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 135. Zhejiang Anbao Pharmaceutical Recent Development
 Table 136. Jiangsu Zhongtian Pharmaceutical Company Details
 Table 137. Jiangsu Zhongtian Pharmaceutical Business Overview
 Table 138. Jiangsu Zhongtian Pharmaceutical Dextromethorphan Product
 Table 139. Jiangsu Zhongtian Pharmaceutical Revenue in Dextromethorphan Business (2020-2025) & (US$ Million)
 Table 140. Jiangsu Zhongtian Pharmaceutical Recent Development
 Table 141. Research Programs/Design for This Report
 Table 142. Key Data Information from Secondary Sources
 Table 143. Key Data Information from Primary Sources
 Table 144. Authors List of This Report


List of Figures
 Figure 1. Dextromethorphan Picture
 Figure 2. Global Dextromethorphan Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Dextromethorphan Market Share by Type: 2024 VS 2031
 Figure 4. Tablets Features
 Figure 5. Syrups Features
 Figure 6. Global Dextromethorphan Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Dextromethorphan Market Share by Application: 2024 VS 2031
 Figure 8. Cold Case Studies
 Figure 9. Acute Or Chronic Bronchitis Case Studies
 Figure 10. Bronchial Asthma Case Studies
 Figure 11. Sore Throat Case Studies
 Figure 12. Tuberculosis (TB) Case Studies
 Figure 13. Dextromethorphan Report Years Considered
 Figure 14. Global Dextromethorphan Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Dextromethorphan Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Dextromethorphan Market Share by Region: 2024 VS 2031
 Figure 17. Global Dextromethorphan Market Share by Players in 2024
 Figure 18. Global Top Dextromethorphan Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dextromethorphan as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Dextromethorphan Revenue in 2024
 Figure 20. North America Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Dextromethorphan Market Share by Country (2020-2031)
 Figure 22. United States Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Dextromethorphan Market Share by Country (2020-2031)
 Figure 26. Germany Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Dextromethorphan Market Share by Region (2020-2031)
 Figure 34. China Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Dextromethorphan Market Share by Country (2020-2031)
 Figure 42. Mexico Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Dextromethorphan Market Share by Country (2020-2031)
 Figure 46. Turkey Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Dextromethorphan Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Teva Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 50. Sanofi Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 51. Johnson & Johnson Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 52. Bayer Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 54. GSK Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 55. IriSys R&D Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 56. TSH Biopharm Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 57. Endo International Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 58. Axsome Therapeutics Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 59. Strive Pharmaceuticals Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 60. Cellix Bio Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 61. Stada Arzneimittel Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 62. Yabo Pharmaceutical Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 63. Zhuhai Tianda Pharma Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 64. Sichuan Shenghe Pharmaceutical Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 65. Zhejiang Kangde Pharmaceutical Group Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 66. Zhejiang Anbao Pharmaceutical Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 67. Jiangsu Zhongtian Pharmaceutical Revenue Growth Rate in Dextromethorphan Business (2020-2025)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Dextromethorphan Hydrobromide Syrups Market Research Report 2024
Global Dextromethorphan HBr Market Research Report 2025
Global Cough Suppressant Drugs Market Insights Forecast to 2030
Global Dextromethorphan Hydrobromide Oral Solution Market Research Report 2024
Global Codeine Phosphate Tablets Market Research Report 2025
Global Nalmefene Market Research Report 2024
Global Lonotropic Glutamate Receptor Antagonist Market Insights Forecast to 2030
Butorphanol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Nalmefene Hydrochloride API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Levocabastine Drops Market Research Report 2024
Levosalbutamol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Levomethorphan Hydrochloride Market Research Report 2024
Global Nalmefene Hydrochloride Injection Market Research Report 2024
Global R α Methylbenzylamine Market Research Report 2025
Hydromorphone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Levosalbutamole Sulphate API Market Research Report 2024
Global Levomilnacipran Tablets Market Research Report 2024
Global Memantine HCL API Market Research Report 2025
Global NMDA Receptor Antagonist Market Research Report 2025
Opioid Receptor Agonist Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions